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Argania spinosa is an evergreen tree endemic of southwestern Morocco. Many preparations have been
used in traditional Moroccan medicine for centuries to treat several illnesses including diabetes. How-
ever, scientific evidence supporting these actions is lacking. Therefore, we prepared various extracts
of the argan fruit, namely keel, cake and argan oil extracts, which we tested in the HTC hepatoma cell
line for their potential to affect cellular insulin responses. Cell viability was measured by Trypan Blue
exclusion and the response to insulin evaluated by the activation of the extracellular regulated kinase
(ERK1/2), ERK kinase (MEK1/2) and protein kinase B (PKB/Akt) signaling components. None of the
extracts demonstrated significant cytotoxic activity. Certain extracts demonstrated a bi-phasic effect
on ERK1/2 activation; low doses of the extract slightly increased ERK1/2 activation in response to
insulin, whereas higher doses completely abolished the response. In contrast, none of the extracts had
any significant effect on MEK whereas only a cake saponin subfraction enhanced insulin-induced
PKB/Akt activation. The specific action of argan oil extracts on ERK1/2 activation made us consider
an anti-proliferative action. We have thus tested other transformed cell lines (HT-1080 and
MSV-MDCK-INV cells) and found similar results. Inhibition of ERK1/2 activation was also associated
with decreased DNA synthesis as evidenced by [
3H]thymidine incorporation experiments. These results
suggest that the products of Argania spinosa may provide a new therapeutic avenue against proliferative
diseases.
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Introduction
The argan tree (Argania spinosa) is a thorny evergreen tree
that plays an essential ecological and socio-economic role
in southwestern parts of Morocco. A program aimed to
increase the industrial value of Argania spinosa is currently
carried out in Morocco (1,2). All the parts of the tree have
value. Specially, the almond oil is largely used for cooking
or in traditional medicine and represents the argan tree’s
most important product.
Various biological properties largely known by traditional
medicine have received some scientific supports. It is notably
the case for the traditional uses of almond oil to decrease blood
cholesterol and hypertension (3–5), to treat skin diseases such
as juvenile acne and chicken pox pustules (2), or for other
beneficial effects of saponin derivatives, notably analgesic
and anti-inflammatory (6), anti-microbial (2) and lipolytic
properties (2).
Chemical analysis revealed that argan oil is particularly well
balanced in terms of fatty acid composition (2,7). Argan oil is
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monounsaturated fatty acids (especially oleic acid). Essential
fatty acids represent 36% (especially linoleic acid) (8). Studies
with the unsaponifiable fraction of the oil highlighted antioxid-
ant compounds present in relatively high concentrations
(mainly tocopherols). Argan oil is also known to contain phen-
olic constituents like caffeic, vanillic and ferulic acids, as well
as tyrosol, and sterols like schottenol, spinasterol and finally
squalene (2,8,9).
Recently we became aware of claims for a potential anti-
diabetic action of Argania spinosa almonds that has not been
scientifically validated to date (Z. Charrouf, unpublished
data). Diabetes has become a worldwide epidemic disease
with over 170 million people suffering from it (10). The vast
majority of cases are of the so-called Type 2 Diabetes Mellitus
(T2DM). There exists a genetic predisposition to the disease
that is precipitated by environmental factors such as a sedent-
ary lifestyle and unhealthy eating habits, obesity being one of
the most prominent risk factors. T2DM is characterized by
an insensitivity of peripheral tissues to the action of insulin,
termed insulin resistance.
Binding of insulin to its specific cell surface receptor
induces receptor autophosphorylation that triggers the
activation of two main intracellular signaling pathways: the
phosphatidyl-inositol-3-kinase (PI3K) pathway involved in
glucose transport and glycogen synthesis, and the extra-
cellular regulated kinase (ERK) pathway involved in gene
expression and cell proliferation mechanisms (11). Resistance
to insulin can appear at various levels of these signaling
pathways (11).
We therefore explored the claimed anti-diabetic potential of
argan seeds by examining the effects of various extracts on an
insulin-responsive cell line. More specifically we looked at the
potential of our argan extracts to increase the in vitro PI3K and
ERK responses to insulin in HTC cells, a cell line of hepatic
origin. One of the saponin extracts had a stimulatory effect
on the PI3K cascade, compatible with an anti-diabetic poten-
tial. However we observed an inhibitory action specifically
on ERK for a majority of the extracts. This unexpected result
prompted us to explore the anti-proliferative effect of pertin-
ent argan seed extracts on transformed cells of human and can-
ine origin.
Materials and Methods
Chemicals
Phospho-specific antibodies p44/42 MAPK
Thr202, PKB/
Akt
Ser473, MEK1/2
Ser217 and corresponding non-phospho-
specific antibodies corresponding kits were purchased from
Cell Signaling Technology (Beverly, MA). Bovine pancreas
insulin as well as other chemicals were obtained from
Sigma-Aldrich Canada (Oakville, ON). Tritiated thymidine
([methyl-
3H] TdR; 4.0 Ci/mmol) was procured from MP
Biomedicals, LLC (Irvine, CA).
Argania spinosa Extracts
The Argania spinosa extracts were prepared at the Chemistry
Laboratory of Plants Chemistry, Organic and Bioorganic Syn-
thesis headed by Prof. Z. Charrouf. The argan fruit almonds,
cake and oil were kindly provided by the Argan Oil Womens
Cooperative (Targanine), Morocco, and prepared according
to procedures previously described (8,12,13). Figure 1
summarizes the preparation of different extracts. All extraction
procedures were carried out under normal lighting conditions.
Almond extract A1 was obtained by macerating ground argan
almonds (407 g) at room temperature in 80% methanol for 36 h
with agitation. The solvent was then evaporated and the
residue dried to obtain a fine whitish powder (42.4 g: 10.4%
yield; Fig. 1). Almonds were also mechanically pressed at
50–60 C in order to separate argan oil and press cake. The
press cake (543 g starting material) was first defatted with
hexane and extracted with methanol at room temperature
giving extract B1 (54.3 g: 10% yield). Additionally, two
saponin fractions were obtained from the press cake following
extraction with methanol as follows. The methanol extract B1
was partitioned between water and chloroform; the water
soluble portion was successively extracted with ethyl acetate
and n-butanol. The n-butanol extract (6.8 g) was dissolved in
minimum water and chromatographed on diaon HP20 column
(80 · 2 cm) sequentially with water, 30% MeOH and 100%
MeOH. After evaporation of MeOH from the last fraction,
the polar fraction of press cake saponins B2 (2.1 g) and a less
polar fraction from the 30% methanol B3 extract (1.2 g)
were obtained, the latter being collected after treating the
water soluble portion with n-butanol. Finally, an unsaponifi-
able fraction C1 was obtained from argan oil. The oil (20 g
starting material) was well mixed with 200ml of ethanol and
potassium hydroxide (KOH2N/EtOH analysis) and heated
(at  44 C) with backward flow for 1 h. Following addition
of distilled water (200 ml) and cooling to room temperature,
hexane was added (150 ml). This mixture was shaken vigor-
ously for 1 h and the partitioned hexane layer was collected.
The remaining aqueous phase was extracted twice more with
hexane (150 ml). The hexane extracts were pooled, washed
with water/ethanol (50 : 50), dehydrated over anhydrous
Na2SO4 and filtered. The solvent was removed using a rotava-
por. The residue (1.2 g) was heated at 103 C for 1 h. Cake sap-
onin extracts B2 and B3 were dissolved in water. The three
other extracts namely A1, B1 and C1 were dissolved in
DMSO. The maximal DMSO content in culture medium was
set at 0.1 % (v/v).
Cell Culture
HTC cells express insulin receptors and signaling pathways
similar to those found in primary rat hepatocytes (14,15).
HTC cells were cultured in minimal essential medium
(MEM) (Sigma, St Louis), supplemented with 5% fetal bovine
serum (FBS) and 1% penicillin-streptomycin at 37 C under a
humidified atmosphere of 5% CO2/95% air.
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cell line, and the invasive variant of Moloney Sarcoma Virus
transformed Madin-Darby Canine Kidney cells (MSV-
MDCK-INV) (16) possessing motile and invasive properties.
They were cultured in Dubelcco’s minimal essential medium
(DMEM) containing 10% FBS, 2 mM glutamine, 1% non-
essential amino acids, 0.5% vitamins, 1% penicillin and
streptomycin under 5% CO2 atmosphere at 37 C (16,17).
Cell Viability Studies
Confluent cells were incubated in MEM þ 0.5% FBS with
different doses of extracts. Following 6 or 21 h incubation
periods, cells were rinsed with calcium-free PBS (137 mM
NaCl, 2.68 mM KCl, 1.47 mM KH2PO4 and 8.1 mM
Na2HPO4, pH 7.4) and loosened with trypsin (0.05% trypsin
and 0.53 mM EDTA) for 5 min at 37 C. Cell viability
was then determined by Trypan Blue exclusion (0.2% final
concentration).
Treatments
Confluent HTC cells were rinsed and incubated in MEM con-
taining 0.5% FBS and extracts at different doses (12.5, 25, 50
and 100 mgm l
 1) for periods of 5 or 20 h. Additional 1 h
incubation with fresh extracts was done in serum-free medium.
This procedure ensured that intracellular signaling pathways
activated by growth factors resumed baseline activity. Follow-
ing treatments with extracts, insulin (0–100 nM final concen-
tration) was added to the medium for 5 min at 37 C. The
stimulation was stopped by quickly removing the medium
and washing the cells twice with ice-cold phosphate-buffered
saline (PBS). Cells were solubilized in lysis buffer [25 mM
Tris–HCl, pH 7.4, 25 mM NaCl, 0.5 mM EDTA, 1% Triton
X-100, 0.1% SDS, protease inhibitors (2 mM benzamide,
1 mM phenylmethanesulfonyl fluoride and 10 mgm l
 1
aprotinine) and the phosphatase inhibitors (10 mM sodium flu-
oride, 1 mM sodium orthovanadate and 10 mM sodium pyro-
phosphate)]. Lysis was carried out for 5 min on ice followed
by scraping. Lysates were recovered and insoluble material
was removed by centrifugation (4500 g for 10 min) at 4 C.
The supernatant was kept at  80  C until analyzed.
HT-1080 and MSV-MDCK-INV cells were seeded at
1.80 · 10
5 cells per 60 mm plate and cultured as indicated
for  24 h before use. About 18 h before the beginning of the
incubation, at 60–70% confluence, the initial medium was
changed for a DMEM medium containing 0.5% FBS. Cells
were then incubated with serum-free medium containing
Argania spinosa extracts (doses ranging from 0.79 to
Figure 1. Steps involved in the preparation of various argan almond extracts. Details are described in the Materials and Methods section. The different extracts are
as follows: A1, methanolic almond extract; B1, methanolic press cake extract; B2, more polar saponin press cake fraction (extracted with 100% MeOH); B3, less
polar saponin press cake fraction (extracted with 30% MeOH); and C1, unsaponifiable argan oil extract. All extraction procedures were carried out at room
temperature, except where indicated.
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 1 as indicated) for 6 h. Cells were washed
three times with PBS/CM (PBS/0.1 mM CaCl2,1m M
MgCl2), and lysed with 3· Laemmli sample buffer (15% b-
mercaptoethanol, 7.5% SDS, 30% glycerol, 300 mM Tris–HCl
pH 6.8 and bromophenol blue) heated at 95 C. The cell lysates
were harvested and kept at  80 C pending immunoblot
assays.
Immunoblot Analysis
Cell lysates were subjected to electrophoresis on 10%
SDS-polyacrylamide gels, transferred to nitrocellulose mem-
branes and blotted with phospho-specific p42/44 MAPK
Thr202
(1 : 2000), PKB/Akt
Ser473 (1/1000) or MEK1/2
Ser217 (1 : 2000)
antibody. Equal protein loading was routinely ascertained fol-
lowing transfer to nitrocellulose membranes by Ponceau Red
staining. Moreover non-phosphorylated forms of the proteins
were detected by following antibodies stripping and incubation
of membranes with pan-specific antibodies, namely anti-Akt
(1 : 1000), anti-ERK1/2 (1 : 1000) or anti-MEK1/2 (1 :
1000). The antibody-antigen complexes were detected with
anti-mouse or anti-rabbit antibodies coupled with horseradish
peroxidase and detected using an enhanced chemilumines-
cence kit (Perkin Elmer, Boston, MA).
Anti-proliferative Activity
HT-1080 and MSV-MDCK-INV cells were seeded into
24-wellplatesatadensityof1 · 10
5cellsperwellandcultured
24 h in 10% FCS supplemented medium. They were starved in
serum-free medium for another 24 h and then incubated for
16 h with fresh serum-free medium containing different
concentrations (0.195, 0.39, 0.78, 1.56, 3.12, 6.25 and
12.5 mgm l
 1) of C1. Medium was then removed and replaced
with serum-free medium supplemented with fresh extract and
[
3H]thymidine (1 mCi ml
 1) for 4 h at 37 C. Proteins were
precipitated with cold 5% trichloroacetic acid (TCA), washed
with water and the cells lysed with NaOH 0.1 N. The radio-
activity incorporated was counted in a liquid-scintillation beta
counter. The results were expressed as a function of maximal
incorporation, and each value was normalized for respective
protein content.
Results
Argania spinosa Extracts are not Cytotoxic
We first examined the effects of the different argan seed
extracts on HTC viability. As shown in Table 1 the extracts
do not exhibit any cytotoxic activity toward HTC cells. This
was true for concentrations as high as 50 mgm l
 1 and for
incubation periods of 6 or 21 h.
Methanol Extracts of A. spinosa Almonds and Cake
Exhibit Bi-phasic Modulation of Insulin Signaling in
HTC Cells
Next, HTC cells were treated with various argan seed extracts
for 6 or 21 h and their action on the cells’ responsiveness to
insulin was assessed by measuring phosphorylation of
ERK1/2 and Akt/PKB. Treatment of HTC cells with the
methanolic extract of argan almond (A1) or cake (B1) induced
a bi-phasic effect on the response of ERK1/2 and, to lesser
extent of Akt, to insulin stimulation. Indeed, short- or long-
term exposure of cells to 12.5 mgm l
 1 of A1 (Fig. 2A and B,
respectively) and B1 (Fig. 3A and B) enhanced slightly the
activation of ERK1/2. However increasing A1 concentration
to 25 mgm l
 1 completely abolished ERK1/2 response
and diminished that of Akt after either 6 or 21 h incubation
(Fig. 2C and D). This bi-phasic behavior is highlighted
in Fig. 2E, where Akt and ERK1/2 activation is presented in
relation to respective DMSO controls for both concentrations
of A1 extract used over a 6 h period. Similar results
were observed with B1 at 25 mgm l
 1 (results not illustrated).
A. spinosa Cake Polar Saponins Selectively Enhance
Insulin-dependent Akt Activation in HTC Cells
In contrast, B2 saponin extract increased Akt phosphorylation
without affecting that of ERK1/2. As illustrated in Fig. 3E, the
positive effect of B2 extract on Akt phosphorylation was more
pronounced after a 21 h incubation period (immunoblot in
Fig. 3D) as compared with 6 h (immunoblot in Fig. 3C, see
also Fig. 3E). On the other hand, B3 extract did not have any
significant effect on either ERK1/2 or Akt/PKB activation by
insulin, be it after 6 or 21 h incubations (Fig. 3C and D,
respectively).
The Unsaponifiable Fraction of A. spinosa Oil Extract
Selectively and Potently Inhibits Insulin-dependent and
Insulin-independent ERK1/2 Activation in HTC Cells
The unsaponifiable extract of argan oil, C1, had a different
pattern of action on HTC liver cells. At a concentration of
25 mgm l
 1, C1 treatment reduced the ability of ERK1/2 to
respond to increasing doses of insulin, whereas the Akt res-
ponse remained undisturbed. This effect became more promin-
ent at a concentration of 50 mgm l
 1. The ERK1/2 response
was abolished completely when C1 incubation time was
Table 1. In vitro cytotoxicity of argan extracts on HTC cells
Treatment % Viability
6 h 21 h
DMSO 98.6 ±0.10 99.0 ±0.16
H2O 98.7 ±0.15 99.6 ±0.21
A1 97.5 ±0.55 97.0 ±0.52
B1 98.7 ±0.46 97.4 ±0.47
B2 97.3 ±0.98 98.5 ±1.47
B3 97.8 ±0.12 97.5 ±0.10
C1 98.8 ±0.48 95.3 ±0.44
The cells were exposed to 50 mgm l
 1 of each extract for 6 or 21 h and viability
was then determined by Trypan Blue (0.2%) exclusion. The suitable controls
(DMSO or H2O) were carried out as indicated in the Materials and Methods
section.
320 Molecular action of argan seed extractsincreased from 6 to 21 h (Fig. 4). Cell lysates were then probed
for phosphorylated MEK1/2, the kinases lying immediately
upstream of ERK1/2 in this insulin-signaling cascade. As
shown in Fig. 4, insulin-induced activation of MEK1/2 was
not decreased by C1 extract irrespective of the dose or incuba-
tion period used. If anything, treatment with C1 extract
appeared to slightly increase basal MEK1/2 phosphorylation.
The Unsaponifiable Fraction of A. spinosa Oil Extract
Inhibits Proliferation of Several Transformed Cell
Lines in a Dose-dependent Manner through
ERK1/2 Inactivation
These intriguing results indicated that C1 extract could specif-
ically interrupt the insulin-signaling cascade between MEK1/2
and ERK1/2. In view of the fact that this signaling cascade is
involved in the proliferative action of insulin (also shared by
growth factors), it seemed appropriate to examine the anti-
proliferative effect of C1. For this purpose, we selected two
cell lines of tumorigenic origin, namely the human HT-1080
fibrosarcoma cell line and the transformed and invasive canine
MSV-MDCK-INV cells. As shown in Fig. 5, exposure to
increasing concentrations of C1 extract inhibited DNA syn-
thesis in both cell types in a dose-dependent manner. At a
dose of 12.5 mgm l
 1, C1 completely abolished [
3H]thymidine
incorporation. When the activation states of MEK1/2 and
ERK1/2 were examined, a dose of 12.5 mgm l
 1 of C1 strongly
inhibited ERK1/2 without affecting MEK1/2 (Fig. 6). This
behavior is similar to that seen previously in HTC cells
(Fig. 4). Furthermore, the effect of C1 extract was comparable
to that of U0126 a well-known inhibitor of MEK1/2 activity.
Hence, C1 possesses strong anti-proliferative activity that
appears to be mediated by the interruption of signaling cas-
cades at the MEK1/2–ERK1/2 interface.
Discussion
It recently came to our attention through Moroccan folk medi-
cine that argan almond may be benefical for the treatment of
diabetes (Z. Charrouf, unpublished data). This study was thus
carried out to examine the potential anti-diabetic action of
various fractions of the seed of the argan tree, Argania spinosa,
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Figure 2. Concentration-dependent effects of methanolic almond extract on major insulin-signaling pathways. HTC cells cultured for 6 h (A and C) and 21 h
(B and D) in the presence of 12.5 mgm l
 1 (A and B) or 25 mgm l
 1 (C and D) of A1 extract. Treated or control cells were then stimulated with indicated concen-
trations of insulin (Ins) after treatment by A1 extract. The cells were lysed and 20 mg of SDS-lysis protein extract were used for western blot analysis as described in
the Materials and Methods section. Proteins immunoreactive to antibodies raised against the phosphorylated forms of ERK1/2 (p-ERK1/2) and PKB/Akt (p-Akt)
were revealed by enhanced chemiluminescence as described in the Materials and Methods section. The non-phosphorylated proteins were revealed on stripped
membrane as loading controls. Results are representative of three separate determinations. Densitometric analysis of results with 6 h treatment with both concen-
trations of A1 extract is presented in panel E. Values obtained with A1 are presented relative to their respective DMSO controls at each insulin concentration.
Statistically different from respective DMSO control, *P < 0.05.
eCAM 2006;3(3) 321and to begin exploring their mechanism of action. Methanolic
extracts of the almonds (A1), and cake (B1), were prepared as
well as two fractions of cake saponins (B2 and B3) and an
unsaponifiable fraction of argan oil (C1). None of the fractions
exhibited any cytotoxic activity toward a model liver cell line,
HTC cells.
Being an insulin-responsive cell type, HTC cells were used
to test the hypothesis that some of the Argania spinosa seeds
extract may exert some insulin-sensitizing action. We meas-
ured two key enzymes involved in mediating the physiological
responses to insulin in target cells. Akt/PKB lies downstream
of phosphatidyl-inositol-3-Kinase (PI3K) and mediates the
effect of insulin to enhance glucose transport in muscle and
adipose tissues (11). The enzyme ERK1/2, on the other hand,
is implicated in the action of insulin on gene transcription
and cell division (11). In the liver, both enzymes participate
in insulin-stimulated glycogen synthesis (18). Figure 7 sum-
marizes the results obtained in the present studies.
Firstly, total methanolic extracts of the almond (A1) and
press cake (B1) had a bi-phasic (concentration-dependent)
effect on ERK1/2 and Akt activation by insulin (Fig. 7). A con-
centration of 12.5 mgm l
 1 of A1 had a small stimulating
action on both enzymes, whereas 25 mgm l
 1 strongly inhib-
ited ERK 1/2. When a saponin-rich fraction of the pressed
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Figure 3. Effect of methanolic press cake extract B1 and press cake saponins B2 and B3 on insulin response in HTC cells.HTC cells were treated for 6 h (A and C)
and 21 h (B and D) with B1 (A and B), B2 and B3 (C and D) extracts followed by stimulation with indicated concentrations of insulin. The cells were lysed and 20
mg of SDS-lysis protein extract were used for western blot analysis as described in the Materials and Methods section. Proteins immunoreactive to antibodies raised
against the phosphorylated forms of ERK1/2 (p-ERK1/2) and PKB/Akt (p-Akt) were revealed by enhanced chemiluminescence as described in the Materials and
Methods section. The non-phosphorylated proteins were revealed on stripped membrane as loading controls. Results are representative of three separate determ-
inations. Densitometric analysis of results for p-Akt and p-ERK1/2 in response to B2 treatment for 6 and 21 h is presented in E and F, respectively. Statistically
different from respective DMSO control, *P < 0.05.
322 Molecular action of argan seed extractscake was extracted with 100% methanol (B2 extract), a more
potent stimulatory effect on insulin-induced Akt activation
was uncovered and modulation of ERK1/2 was lost. In con-
trast, isolating the unsaponifiable fraction from argan oil C1
extract yielded the loss of enhanced Akt activation but was
characterized with a powerful inhibitory action at the level of
ERK1/2. This result along with the bi-phasic nature of the
effects of cruder almond and pressed cake extracts argues for
the presence of at least two active components in seeds of
Argania spinosa.
A first component appears to be present in the B2 saponin
fraction of the pressed cake and could underlie an insulin-
sensitizing action that offers a possible mechanism for the
alleged anti-diabetic potential of Argania spinosa almonds.
Indeed, previous work by Alaoui et al. (19) demonstrated a
hypoglycaemic effect in rats treated with 100 mg kg
 1 per
day of an oral mixture of press cake saponins that occurred
within one month. The hypoglycaemic effect could be related
to enhanced transport of glucose into adipose or skeletal mus-
cle tissues, which are known to be activated through the PI3K
pathway. Few studies describe hypoglycaemic properties of
the triterpenic type saponins. Yoshikawa et al. (20) have found
that the structure requirements for hypoglycaemic activity
were the olean-12-ene 3, 28-acylated bidesmoside. These
saponins inhibited the increase of serum glucose levels in
glucose-loaded rats; the transfer of glucose from stomach to
small intestine (21,22); and glucose transport at the small
intestinal brush border (21,23). Charrouf et al. (13) have elu-
cidated the structure of saponins present in the pressed cake
of Argania spinosa which are present in the extracts tested
herein. Using high performance liquid chromatography
(HPLC) we have found seven saponins, five of which are novel
molecules. All are similar to saponins used by Yoshikawa and
Matsuda (20). The results of the present study suggest that
such saponins enhance insulin sensitivity in an insulin-
responsive cell line of hepatic origin. Taken together, this
evidence supports the use of Argania spinosa almonds for
the prevention or treatment of diabetes, albeit clinical con-
firmation is still required.
Higher concentrations of the methanolic extracts (A1) of
almond, of the pressed cake (B1) and of the unsaponifiable
fraction (C1) slightly decreased the degree of phosphorylation
of Akt in HTC cells, but induced a complete inhibition of
ERK1/2 phosphorylation. The C1 extract specifically reduced
the activation of ERK1/2 without affecting the degree of phos-
phorylation of MEK1/2 on two other transformed cell lines
HT-1080 and MSV-MDCK-INV cells. At high concentration,
its effect is comparable to that of U0126. This MEK inhibitor
does not affect the phosphorylation status of MEK1/2 but
inhibits its catalytic activity by binding to activated MEK
in a non-competitive manner. This prevents the enzyme from
phosphorylating and activating downstream ERK1/2. It is
Figure 4. Unsaponifiable fraction C1 exerts a different action on MEK1/2 and ERK1/2 activity in response to insulin in HTC cells. HTC cells were treated with
25 and 50 mgm l
 1 of C1 extract for 6 h (A) and 21 h (B) then the stimulated with insulin for 5 min before lysates were prepared. The cells were lysed and 20 mgo f
SDS-lysis protein extract were used for western blot analysis as described in the Materials and Methods section. Proteins immunoreactive to antibodies raised
against the phosphorylated forms of ERK1/2 (p-ERK1/2) and PKB/Akt (p-Akt) were revealed by enhanced chemiluminescence as described in the Materials
and Methods section. The non-phosphorylated proteins were revealed on stripped membrane as loading controls. Results are representative of three separate
determinations.
eCAM 2006;3(3) 323conceivable that C1 may inhibit MEK activity in a similar
manner. Alternatively, C1 could inhibit the phosphorylation
of ERK1/2 by another mechanism, such as activation of a spe-
cific phosphatase. Further studies will be necessary to address
this point. Nevertheless, these results definitively point toward
an anti-proliferative activity of A1 and C1 extracts rather than
an anti-diabetic one. This was confirmed for C1 by a reduction
of [
3H]thymidine incorporation.
Argania spinosa almonds and press cake have not yet been
subjected to detailed phytochemical analysis. In contrast,
some phenolic compounds have been identified in argan oil
including ferrulic acid, vanillic acid, tyrosol and syringic
acid, carotenoids (8), cafeic acid and oleuropein (24). The
unsaponifiable fraction of argan oil is rich in lipid-soluble vit-
amins, phytosterols, triterpenes, carotenoids and squalene
components believed to confer cancer chemopreventive poten-
tial (8,25,26).
Phenolic or flavonoid compounds had long been recognized
as potent antioxidants (27,28). Antioxidants are believed to
play a role in cancer prevention (29,30), although the exact
mechanisms have not been elucidated. In relation to the pre-
sent studies, it must be noted that some flavonoids have shown
an ability to inhibit the MEK/ERK cascade in rat hepatoma
5L cells (31). More specifically, the flavonoid naringenin
impaired the PI3K and MAPK pathways; it inhibits the phos-
phorylation of ERK1/2 without affecting the upstream kinase,
MEK (27). This is similar to the effect of A1, B1 (not shown)
and C1 extract observed herein. Moreover the antitumor effect
of another flavonoid, nobiletin, on human fibrosarcoma
HT-1080 cells (28) was associated with the inhibition of
MEK1/2 activity without influencing the activity of PI3K or
the phosphorylation of Akt. Finally, ferulic acid exhibits a
potent anti-proliferative effect through inhibition of ERK1/2
pathway (32). It is thus possible that flavonoids contained in
the almond of Argania spinosa could participate in the
inhibition of ERK1/2 pathway and be involved in the observed
anti-proliferative activity. We do not expect the C1 fraction to
contain flavonoids but it is possible that other components of
the unsaponifiable fraction may have the same mechanism
of action.
Components such as lipid-soluble vitamins, specifically vit-
amin E, may be involved in the action of C1 extract. Indeed,
argan oil is rich in tocopherols (700 mg Kg
 1) (8); principally
g-tocopherol (75%) and a-tocopherol (7%). g-tocopherol is
known for its cancero-preventive properties (33–36).
a-tocopherol is also known to inhibit proliferation of cancer
cells (37) and to interfere with signal transduction pathways
such as PKC and ERK (38).
In addition, the unsaponifiable fraction of argan oil shows a
particular wealth of phytosterols, principally in the form of
schottenol (48%) and spinasterol (40%), with minor amounts
of d
8-22-stigmastadiene-3b-ol. These sterols are very rare in
vegetable oils. Schottenol has been reported to exhibit anticar-
cinogenic, cytotoxic properties (39) and strong antitumor
promoter activity (40). The anti-proliferative and anti-
tumorigenic potential of spinasterol has also been demon-
strated (41–43). Finally, some triterpenes, such as lupeol
contained in argan oil unsaponifiable fraction, can target mul-
tiple signaling pathways leading to induction of apoptosis and
inhibition of cell growth (44,45). Even if comparable to that of
several natural compounds, such as certain flavonoids, the
effect of these unsaponifiable components on signaling path-
way enzymes is as yet unclear. Nonetheless, phytosterols,
tocopherols and triterpenes in C1 extract could all contribute
to its anti-proliferative activity.
Finally, squalene is another important component of
argan oil (320 mg Kg
 1) known as an excellent
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Figure 5. [
3H]thymidine incorporation by HT-1080 and MSV-MDCK-INV
cells following treatment with C1 extract. HT-1080 (A) and MSV-MDCK-INV
(B) cells were seeded in 24-well plates and serum removed after 24 h. Cells
were then incubated in serum-free medium in the presence of the extract for
6 h then in the presence of extract and 1 mCi ml
 1 [
3H]thymidine 1 mCi ml
 1)
for another 4 h. Radioactivity was counted on NaOH extracts. The results
are expressed according to maximal incorporation in the presence of DMSO;
each value having been corrected for the quantity of proteins in each well.
Measurements were done in triplicate and are the mean of two separate
experiments.
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of oncogenic activity (46,47). Squalene has also been reported
to exert anti-tumorigenic (48) or anticarcinogenic effects (47)
as well as glutathione-like cytoprotective activity (49). Finally,
the anti-proliferative activity of squalene appears to involve
inhibition of the Ras/Raf/MEK/ERK pathway (50).
Conclusion
While many single components of Argania spinosa seeds
could be responsible for the effects observed in this study, syn-
ergy or antagonism between multiple components is also
likely. However, using a fractionation approach can help
unravel such complexities. Indeed, we prepared several
extracts from argan seeds, its oil and remaining press cake.
This allowed us to demontrate an insulin-sentitizing activity
present in saponin-rich presscake fractions that lends support
to the traditional use of argan almonds against diabetes. How-
ever, a bi-phasic modulation of ERK1/2 component of the
insulin response by treatment with argan seed extract could
be explained by anti-proliferative components concentrated
in the unsaponifiable fraction of argan oil. Hence, our studies
confirm in part the anti-diabetic and cancer chemopreventive
potential of Argania spinosa seeds. They further suggest that
active principles for each action may reside in different frac-
tions and this may help their identification in future studies.
Moreover, natural health products of vegetable origin were
clearly identified as a promising avenue for the prevention of
chronic diseases (51), as raised notably by a panel of experts
that convened in Montreal in 2004 (52). Our study supports
the concept that A. spinosa almonds, oil, and extracts thereof
Figure 6. ERK1/2 and MEK1/2 phosphorylation status in HT-1080 and MSV-MDCK-INV cells after C1 treatment. Lysates obtained from HT-1080 (A) and
MSV-MDCK-INV (B) cells after exposition to unsaponifiable fraction C1 at the indicated concentrations or to 10 mM UO126 were blotted against the phos-
phorylated or non-phosphorylated forms of MEK1/2 and ERK1/2, respectively.
UNSAPONIFIABLE
FRACTION
ALMOND
CAKE
ARGAN OIL
SAPONINS
A1
methanol B1
methanol
C1
B2
Press
25 µg/ml ↓ ↓ ↓ ↓↓ ↓ ↓ ↓ ERK 1/2
↑ ↑ ↑ ↑↑ ↑ ↑ ↑ Akt
↓ ↓ ↓ ↓↓ ↓ ↓ ↓↓ ↓ ↓ ↓ ERK 1/2
↓ ↓ ↓ ↓↓ ↓ ↓ ↓↓ ↓ ↓ ↓ Tumour cell proliferation
Similar to A1
12.5 µg/ml ↑ ↑ ↑ ↑ Akt
↑ ↑ ↑ ↑ ERK 1/2
Figure 7. Summary of the biological effects of Argania spinosa extracts.
eCAM 2006;3(3) 325are part of such natural health products that can be useful in
the prevention of serious chronic illnesses like cancer and
diabetes.
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